Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium
Abstract Background Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, however, no GMP-manufactured product is available and treatment data in European travellers are scarce. Fortunately, artesunate became available in the Netherlands and Belgium through a named patient programme. This is the largest case series of artesunate treated patients with severe malaria in Europe. Methods Hospitalized patients treated with IV artesunate between November 2007 and December 2010 in the Netherlands and Belgium were retrospectively evaluated. Patient characteristics, trea... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2012 |
Reihe/Periodikum: | Malaria Journal, Vol 11, Iss 1, p 102 (2012) |
Verlag/Hrsg.: |
BMC
|
Schlagwörter: | Intravenous artesunate / Severe malaria / Parasite clearance / Named patient program / European traveller / Arctic medicine. Tropical medicine / RC955-962 / Infectious and parasitic diseases / RC109-216 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28971945 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1186/1475-2875-11-102 |